109 related articles for article (PubMed ID: 9161752)
1. Do enflurane and isoflurane interfere with the release, action, or stability of endothelium-derived relaxing factors?
Blaise G; Guy C; To Q; Sauvé R
Can J Anaesth; 1997 May; 44(5 Pt 1):550-8. PubMed ID: 9161752
[TBL] [Abstract][Full Text] [Related]
2. Does halothane interfere with the release, action, or stability of endothelium-derived relaxing factor/nitric oxide?
Blaise G; To Q; Parent M; Lagarde B; Asenjo F; Sauvé R
Anesthesiology; 1994 Feb; 80(2):417-26. PubMed ID: 8311324
[TBL] [Abstract][Full Text] [Related]
3. Effects of volatile anesthetics on acetylcholine-induced relaxation in the rabbit mesenteric resistance artery.
Akata T; Nakashima M; Kodama K; Boyle WA; Takahashi S
Anesthesiology; 1995 Jan; 82(1):188-204. PubMed ID: 7832300
[TBL] [Abstract][Full Text] [Related]
4. Acetylcholine stimulates release of endothelium-derived relaxing factor in coronary arteries of human organ donors.
Blaise GA; Stewart DJ; Guérard MJ
Can J Cardiol; 1993 Nov; 9(9):813-20. PubMed ID: 8281481
[TBL] [Abstract][Full Text] [Related]
5. Halothane, enflurane, and isoflurane attenuate both receptor- and non-receptor-mediated EDRF production in rat thoracic aorta.
Uggeri MJ; Proctor GJ; Johns RA
Anesthesiology; 1992 Jun; 76(6):1012-7. PubMed ID: 1599087
[TBL] [Abstract][Full Text] [Related]
6. Volatile anesthetics affect calcium mobilization in bovine endothelial cells.
Pajewski TN; Miao N; Lynch C; Johns RA
Anesthesiology; 1996 Nov; 85(5):1147-56. PubMed ID: 8916833
[TBL] [Abstract][Full Text] [Related]
7. The effects of native LDL and oxidized LDL on EDRF bioactivity and nitric oxide production in vascular endothelium.
Myers PR; Wright TF; Tanner MA; Ostlund RE
J Lab Clin Med; 1994 Nov; 124(5):672-83. PubMed ID: 7964125
[TBL] [Abstract][Full Text] [Related]
8. Endothelium-derived relaxing factor and nitric oxide possess identical pharmacologic properties as relaxants of bovine arterial and venous smooth muscle.
Ignarro LJ; Buga GM; Byrns RE; Wood KS; Chaudhuri G
J Pharmacol Exp Ther; 1988 Jul; 246(1):218-26. PubMed ID: 2839663
[TBL] [Abstract][Full Text] [Related]
9. Endothelium-derived relaxing factor is a selective relaxant of vascular smooth muscle.
Shikano K; Berkowitz BA
J Pharmacol Exp Ther; 1987 Oct; 243(1):55-60. PubMed ID: 3499504
[TBL] [Abstract][Full Text] [Related]
10. Isoflurane inhibits endothelium-mediated nitric oxide relaxing pathways in the isolated perfused rabbit lung.
Oshima Y; Ishibe Y; Okazaki N; Sato T
Can J Anaesth; 1997 Oct; 44(10):1108-14. PubMed ID: 9350373
[TBL] [Abstract][Full Text] [Related]
11. Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor.
Palmer RM; Ferrige AG; Moncada S
Nature; 1987 Jun 11-17; 327(6122):524-6. PubMed ID: 3495737
[TBL] [Abstract][Full Text] [Related]
12. Endothelial cyclic GMP and cyclic AMP do not regulate the release of endothelium-derived relaxing factor/nitric oxide from bovine aortic endothelial cells.
Kuhn M; Otten A; Frölich JC; Förstermann U
J Pharmacol Exp Ther; 1991 Feb; 256(2):677-82. PubMed ID: 1847208
[TBL] [Abstract][Full Text] [Related]
13. Inhibition by sulfhydryl compounds of vascular relaxation induced by nitric oxide and endothelium-derived relaxing factor.
Jia L; Furchgott RF
J Pharmacol Exp Ther; 1993 Oct; 267(1):371-8. PubMed ID: 8229764
[TBL] [Abstract][Full Text] [Related]
14. Para-bromophenacyl bromide inhibits endothelium-dependent arterial relaxation and cyclic GMP accumulation by effects produced exclusively in the smooth muscle.
Johns RA; Peach MJ
J Pharmacol Exp Ther; 1988 Mar; 244(3):859-65. PubMed ID: 2855247
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-dependent effects of halothane, enflurane, and isoflurane on isolated rat aortic vascular rings.
Stone DJ; Johns RA
Anesthesiology; 1989 Jul; 71(1):126-32. PubMed ID: 2751124
[TBL] [Abstract][Full Text] [Related]
16. Endothelium-derived relaxing factor (EDRF) from cultured and fresh endothelial cells.
Gryglewski RJ; Trybulec M; Radziszewski W; Swierkosz T; Dudek R; Zembowicz A
Biomed Biochim Acta; 1988; 47(10-11):S61-6. PubMed ID: 2470361
[TBL] [Abstract][Full Text] [Related]
17. LY 83583 interferes with the release of endothelium-derived relaxing factor and inhibits soluble guanylate cyclase.
Mülsch A; Busse R; Liebau S; Förstermann U
J Pharmacol Exp Ther; 1988 Oct; 247(1):283-8. PubMed ID: 2902213
[TBL] [Abstract][Full Text] [Related]
18. Vascular reactivity to endothelium-derived relaxing factor in human umbilical artery at term pregnancy.
Sugawara M; Tohse N; Nagashima M; Yabu H; Kudo R
Can J Physiol Pharmacol; 1997 Jul; 75(7):818-24. PubMed ID: 9315349
[TBL] [Abstract][Full Text] [Related]
19. Bioassay of prostacyclin and endothelium-derived relaxing factor (EDRF) from porcine aortic endothelial cells.
Gryglewski RJ; Moncada S; Palmer RM
Br J Pharmacol; 1986 Apr; 87(4):685-94. PubMed ID: 3085757
[TBL] [Abstract][Full Text] [Related]
20. Flow-induced calcium transients and release of endothelium-derived relaxing factor in cultured vascular endothelial cells.
Ando J; Ohtsuka A; Korenaga R; Sakuma I; Kamiya A
Front Med Biol Eng; 1993; 5(1):17-21. PubMed ID: 8323878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
